New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 16 04:00PM ET
8.61
Dollar change
-1.16
Percentage change
-11.87
%
Index- P/E- EPS (ttm)-12.83 Insider Own1.17% Shs Outstand3.33M Perf Week85.56%
Market Cap28.69M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.29M Perf Month648.70%
Enterprise Value26.72M PEG- EPS next Q-0.49 Inst Own4.84% Short Float1.25% Perf Quarter542.54%
Income-13.29M P/S28.69 EPS this Y69.52% Inst Trans74.16% Short Ratio0.01 Perf Half Y444.94%
Sales1.00M P/B40.61 EPS next Y- ROA-272.65% Short Interest0.04M Perf YTD489.73%
Book/sh0.21 P/C13.93 EPS next 5Y- ROE-714.96% 52W High19.30 -55.39% Perf Year23.49%
Cash/sh0.62 P/FCF- EPS past 3/5Y83.46% 85.27% ROIC-2006.15% 52W Low1.08 697.22% Perf 3Y-98.80%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-66.23% -77.19% Gross Margin91.31% Volatility50.95% 32.58% Perf 5Y-99.90%
Dividend TTM- EV/Sales26.72 EPS Y/Y TTM69.65% Oper. Margin-1376.89% ATR (14)1.69 Perf 10Y-100.00%
Dividend Ex-Date- Quick Ratio1.03 Sales Y/Y TTM978.39% Profit Margin-1328.60% RSI (14)80.15 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.03 EPS Q/Q-240.61% SMA20139.17% Beta0.80 Target Price20.00
Payout- Debt/Eq0.14 Sales Q/Q- SMA50296.24% Rel Volume0.71 Prev Close9.77
Employees13 LT Debt/Eq0.00 EarningsMay 20 SMA200264.38% Avg Volume3.72M Price8.61
IPOJul 27, 2005 Option/ShortNo / Yes EPS/Sales Surpr.0.00% - Trades Volume2,670,936 Change-11.87%
Jul-14-25 06:00AM
May-01-25 09:00AM
Apr-16-25 09:10AM
Apr-04-25 09:00AM
Apr-01-25 04:15PM
07:30AM Loading…
07:30AM
Mar-26-25 09:05AM
Mar-19-25 08:50AM
Mar-11-25 08:45AM
Feb-26-25 09:00AM
Feb-19-25 08:35AM
Feb-18-25 09:15AM
Feb-13-25 08:30AM
08:00AM
Jan-28-25 09:05AM
08:35AM Loading…
Jan-22-25 08:35AM
Jan-21-25 09:05AM
Dec-23-24 09:20AM
Dec-17-24 08:50AM
Dec-09-24 03:42PM
08:45AM
Dec-04-24 09:20AM
Nov-12-24 09:15AM
Nov-06-24 01:20PM
08:30AM
Oct-17-24 08:45AM
Oct-10-24 09:17AM
Oct-09-24 08:45AM
Oct-04-24 08:30AM
Sep-30-24 09:00AM
08:30AM Loading…
Sep-25-24 08:30AM
Sep-18-24 08:30AM
Sep-04-24 09:15AM
Aug-19-24 08:45AM
Aug-14-24 10:56PM
08:35AM
Jul-24-24 03:00PM
08:30AM
Jun-20-24 08:30AM
Jun-13-24 08:00AM
May-28-24 08:00AM
May-22-24 07:00AM
May-20-24 09:15AM
May-15-24 09:53AM
May-14-24 04:15PM
May-06-24 07:00AM
May-03-24 09:00AM
Mar-19-24 07:30AM
Mar-11-24 07:30AM
Feb-29-24 04:05PM
Feb-14-24 07:30AM
Dec-21-23 08:00AM
Dec-14-23 04:15PM
Oct-31-23 07:30AM
Oct-25-23 07:30AM
Oct-17-23 08:00AM
Sep-20-23 07:30AM
Sep-19-23 08:30AM
Aug-31-23 10:55AM
Aug-16-23 07:30AM
Aug-14-23 08:00AM
Jul-31-23 09:00AM
Jun-28-23 08:00AM
Jun-23-23 08:00AM
Jun-20-23 08:00AM
May-10-23 07:30AM
Apr-18-23 04:01PM
Apr-17-23 08:00AM
Mar-14-23 04:31PM
Feb-13-23 08:00AM
Feb-08-23 08:00AM
Feb-01-23 08:00AM
Jan-19-23 08:00AM
Jan-09-23 08:00AM
Dec-15-22 04:05PM
Nov-02-22 08:00AM
Nov-01-22 04:05PM
Oct-31-22 07:30AM
Oct-04-22 08:00AM
Sep-26-22 08:00AM
Sep-21-22 08:00AM
Sep-16-22 08:30AM
Aug-15-22 04:05PM
Jul-22-22 07:00AM
Jul-21-22 07:30AM
Jun-09-22 07:00AM
Jun-02-22 09:25AM
May-10-22 08:15AM
Apr-13-22 07:00AM
Apr-08-22 01:05PM
Mar-16-22 07:00AM
Feb-09-22 06:30AM
Feb-08-22 07:00AM
Dec-20-21 12:58PM
Dec-17-21 06:30AM
Aug-30-21 04:01PM
Aug-19-21 09:35PM
Aug-16-21 06:30AM
Jun-14-21 07:45AM
Jun-08-21 04:30PM
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.